Skip to main content
NCBI home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1992 Oct;5(4):345–355. doi: 10.1128/cmr.5.4.345

Dysregulation of strongyloidiasis: a new hypothesis.

R M Genta 1
PMCID: PMC358253  PMID: 1423214

Abstract

Few other human parasites are associated with such a diverse spectrum of clinical manifestations as Strongyloides stercoralis, yet the basic biological behavior of this unusually versatile worm, particularly with respect to its ability to cause severe disseminated disease in certain hosts, is poorly understood. The current uncritical acceptance of the theory that cell-mediated immunity controls autoinfection has stifled research in other directions. After reviewing what is and is not known about the parasite's behavior in its host, this article explores some of the mechanisms that could be involved in the regulation of the parasite population. Taking the provocative viewpoint that the parasite, not the host, is mainly responsible for the maintenance of a balanced relationship between the two, I propose a new theory that corticosteroids may act on the intraintestinal larvae as molting hormones and directly promote the development of disseminated disease.

Full text

PDF
345

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALCORN M. O., Jr, KOTCHER E. Secondary malabsorption syndrome produced by chronic strongyloidiasis. South Med J. 1961 Feb;54:193–197. doi: 10.1097/00007611-196102000-00013. [DOI] [PubMed] [Google Scholar]
  2. ARTHUR R. P., SHELLEY W. B. Larva currens; a distinctive variant of cutaneous larva migrans due to Strongyloides stercoralis. AMA Arch Derm. 1958 Aug;78(2):186–190. doi: 10.1001/archderm.1958.01560080044007. [DOI] [PubMed] [Google Scholar]
  3. Agbo K., Deniau M. Anguillulospermie rebelle au traitement. A propos d'un cas diagnostiqué au Togo. Bull Soc Pathol Exot Filiales. 1987;80(2):271–273. [PubMed] [Google Scholar]
  4. Akoğlu T., Tuncer I., Erken E., Gürcay A., Ozer F. L., Ozcan K. Parasitic arthritis induced by Strongyloides stercoralis. Ann Rheum Dis. 1984 Jun;43(3):523–525. doi: 10.1136/ard.43.3.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Anderson R. M. The population dynamics and epidemiology of intestinal nematode infections. Trans R Soc Trop Med Hyg. 1986;80(5):686–696. doi: 10.1016/0035-9203(86)90367-6. [DOI] [PubMed] [Google Scholar]
  6. Badaró R., Carvalho E. M., Santos R. B., Gam A. A., Genta R. M. Parasite-specific humoral responses in different clinical forms of strongyloidiasis. Trans R Soc Trop Med Hyg. 1987;81(1):149–150. doi: 10.1016/0035-9203(87)90309-9. [DOI] [PubMed] [Google Scholar]
  7. Baird J. K., De Vinatea M. L., Macher A. M., Sierra J. A., Lasala G. AIDS. Case for diagnosis series, 1987. Mil Med. 1987 Apr;152(4):M17–M24. [PubMed] [Google Scholar]
  8. Berry A. J., Long E. G., Smith J. H., Gourley W. K., Fine D. P. Chronic relapsing colitis due to Strongyloides stercoralis. Am J Trop Med Hyg. 1983 Nov;32(6):1289–1293. doi: 10.4269/ajtmh.1983.32.1289. [DOI] [PubMed] [Google Scholar]
  9. Bhatt B. D., Cappell M. S., Smilow P. C., Das K. M. Recurrent massive upper gastrointestinal hemorrhage due to Strongyloides stercoralis infection. Am J Gastroenterol. 1990 Aug;85(8):1034–1036. [PubMed] [Google Scholar]
  10. Bout D., Haque A., Capron A. Filaricidal effects of cyclosporin-A against Dipetalonema viteae in Mastomys natalensis. Trans R Soc Trop Med Hyg. 1984;78(5):670–671. doi: 10.1016/0035-9203(84)90236-0. [DOI] [PubMed] [Google Scholar]
  11. Brandt de Oliveira R., Voltarelli J. C., Meneghelli U. G. Severe strongyloidiasis associated with hypogammaglobulinaemia. Parasite Immunol. 1981 Summer;3(2):165–169. doi: 10.1111/j.1365-3024.1981.tb00395.x. [DOI] [PubMed] [Google Scholar]
  12. Bueding E., Hawkins J., Cha Y. N. Antischistosomal effects of cyclosporin A. Agents Actions. 1981 Jul;11(4):380–383. doi: 10.1007/BF01982474. [DOI] [PubMed] [Google Scholar]
  13. Burke J. A. Strongyloidiasis in childhood. Am J Dis Child. 1978 Nov;132(11):1130–1136. doi: 10.1001/archpedi.1978.02120360086017. [DOI] [PubMed] [Google Scholar]
  14. Carp N. Z., Nejman J. H., Kelly J. J. Strongyloidiasis. An unusual cause of colonic pseudopolyposis and gastrointestinal bleeding. Surg Endosc. 1987;1(3):175–177. doi: 10.1007/BF00590927. [DOI] [PubMed] [Google Scholar]
  15. Carvalho Filho E. Strongyloidiasis. Clin Gastroenterol. 1978 Jan;7(1):179–200. [PubMed] [Google Scholar]
  16. Colebunders R., Lusakumuni K., Nelson A. M., Gigase P., Lebughe I., van Marck E., Kapita B., Francis H., Salaun J. J., Quinn T. C. Persistent diarrhoea in Zairian AIDS patients: an endoscopic and histological study. Gut. 1988 Dec;29(12):1687–1691. doi: 10.1136/gut.29.12.1687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Corsini A. C. Strongyloidiasis and chronic urticaria. Postgrad Med J. 1982 Apr;58(678):247–248. doi: 10.1136/pgmj.58.678.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Cruz T., Reboucas G., Rocha H. Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med. 1966 Nov 17;275(20):1093–1096. doi: 10.1056/NEJM196611172752003. [DOI] [PubMed] [Google Scholar]
  19. Cummins R. O., Suratt P. M., Horwitz D. A. Disseminated Strongyloides stercoralis infection. Association with ectopic ACTH syndrome and depressed cell-mediated immunity. Arch Intern Med. 1978 Jun;138(6):1005–1006. doi: 10.1001/archinte.138.6.1005. [DOI] [PubMed] [Google Scholar]
  20. Date A., Vaska K., Vaska P. H., Pandey A. P., Kirubakaran M. G., Shastry J. C. Terminal infections in renal transplant patients in a tropical environment. Nephron. 1982;32(3):253–257. doi: 10.1159/000182855. [DOI] [PubMed] [Google Scholar]
  21. Davidson R. A. Strongyloidiasis: a presentation of 63 cases. N C Med J. 1982 Jan;43(1):23–25. [PubMed] [Google Scholar]
  22. DeVault G. A., Jr, Brown S. T., 3rd, Montoya S. F., Jr, King J. W., Rohr M. S., McDonald J. C. Disseminated strongyloidiasis complicating acute renal allograft rejection. Prolonged thiabendazole administration and successful retransplantation. Transplantation. 1982 Oct;34(4):220–221. doi: 10.1097/00007890-198210000-00014. [DOI] [PubMed] [Google Scholar]
  23. DeVault G. A., Jr, King J. W., Rohr M. S., Landreneau M. D., Brown S. T., 3rd, McDonald J. C. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis. 1990 Jul-Aug;12(4):653–671. doi: 10.1093/clinids/12.4.653. [DOI] [PubMed] [Google Scholar]
  24. Debussche X., Toublanc M., Camillieri J. P., Assan R. Overwhelming strongyloidiasis in a diabetic patient following ACTH treatment and keto-acidosis. Diabete Metab. 1988 May-Jun;14(3):294–298. [PubMed] [Google Scholar]
  25. Dees A., Batenburg P. L., Umar H. M., Menon R. S., Verweij J. Strongyloides stercoralis associated with a bleeding gastric ulcer. Gut. 1990 Dec;31(12):1414–1415. doi: 10.1136/gut.31.12.1414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Douce R. W., Brown A. E., Khamboonruang C., Walzer P. D., Genta R. M. Seroepidemiology of strongyloidiasis in a Thai village. Int J Parasitol. 1987 Oct;17(7):1343–1348. doi: 10.1016/0020-7519(87)90101-9. [DOI] [PubMed] [Google Scholar]
  27. Dutcher J. P., Marcus S. L., Tanowitz H. B., Wittner M., Fuks J. Z., Wiernik P. H. Disseminated strongyloidiasis with central nervous system involvement diagnosed antemortem in a patient with acquired immunodeficiency syndrome and Burkitts lymphoma. Cancer. 1990 Dec 1;66(11):2417–2420. doi: 10.1002/1097-0142(19901201)66:11<2417::aid-cncr2820661129>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  28. Fleming A. F. Opportunistic infections in AIDS in developed and developing countries. Trans R Soc Trop Med Hyg. 1990;84 (Suppl 1):1–6. doi: 10.1016/0035-9203(90)90446-l. [DOI] [PubMed] [Google Scholar]
  29. Ford J., Reiss-Levy E., Clark E., Dyson A. J., Schonell M. Pulmonary strongyloidiasis and lung abscess. Chest. 1981 Feb;79(2):239–240. doi: 10.1378/chest.79.2.239. [DOI] [PubMed] [Google Scholar]
  30. Forzy G., Dhondt J. L., Leloire O., Shayeb J., Vincent G. Reactive arthritis and Strongyloides. JAMA. 1988 May 6;259(17):2546–2547. doi: 10.1001/jama.1988.03720170022024. [DOI] [PubMed] [Google Scholar]
  31. GALLIARD H., BERDONNEAU R. Strongyloidose expérimentale chez le chien; effets de la cortisone, résultats du test de Thorn à l'hormone corticotrope (ACTH). Ann Parasitol Hum Comp. 1953;28(3):163–171. [PubMed] [Google Scholar]
  32. GALLIARD H. Recherches sur l'infestation expérimentale a Strongyloides stercoralis au Tonkin (1re note). Ann Parasitol Hum Comp. 1950;25(5-6):441–contd. [PubMed] [Google Scholar]
  33. Garcia F. T., Sessions J. T., Strum W. B., Schweistris E., Tripathy K., Bolaños O., Lotero H., Duque E., Ramelli D., Mayoral L. G. Intestinal function and morphology in strongyloidiasis. Am J Trop Med Hyg. 1977 Sep;26(5 Pt 1):859–865. doi: 10.4269/ajtmh.1977.26.859. [DOI] [PubMed] [Google Scholar]
  34. Genta R. M., Douce R. W., Walzer P. D. Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis. J Clin Microbiol. 1986 Jun;23(6):1099–1103. doi: 10.1128/jcm.23.6.1099-1103.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Genta R. M., Frei D. F., Linke M. J. Demonstration and partial characterization of parasite-specific immunoglobulin A responses in human strongyloidiasis. J Clin Microbiol. 1987 Aug;25(8):1505–1510. doi: 10.1128/jcm.25.8.1505-1510.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Genta R. M., Gatti S., Linke M. J., Cevini C., Scaglia M. Endemic strongyloidiasis in northern Italy: clinical and immunological aspects. Q J Med. 1988 Sep;68(257):679–690. [PubMed] [Google Scholar]
  37. Genta R. M. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis. 1989 Sep-Oct;11(5):755–767. doi: 10.1093/clinids/11.5.755. [DOI] [PubMed] [Google Scholar]
  38. Genta R. M., Harper J. S., 3rd, Gam A. A., London W. I., Neva F. A. Experimental disseminated strongyloidiasis in Erythrocebus patas. II. Immunology. Am J Trop Med Hyg. 1984 May;33(3):444–450. doi: 10.4269/ajtmh.1984.33.444. [DOI] [PubMed] [Google Scholar]
  39. Genta R. M., Lillibridge J. P. Prominence of IgG4 antibodies in the human responses to Strongyloides stercoralis infection. J Infect Dis. 1989 Oct;160(4):692–699. doi: 10.1093/infdis/160.4.692. [DOI] [PubMed] [Google Scholar]
  40. Genta R. M., Miles P., Fields K. Opportunistic Strongyloides stercoralis infection in lymphoma patients. Report of a case and review of the literature. Cancer. 1989 Apr 1;63(7):1407–1411. doi: 10.1002/1097-0142(19890401)63:7<1407::aid-cncr2820630729>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  41. Genta R. M., Ottesen E. A., Neva F. A., Walzer P. D., Tanowitz H. B., Wittner M. Cellular responses in human strongyloidiasis. Am J Trop Med Hyg. 1983 Sep;32(5):990–994. doi: 10.4269/ajtmh.1983.32.990. [DOI] [PubMed] [Google Scholar]
  42. Genta R. M., Ottesen E. A., Poindexter R., Gam A. A., Neva F. A., Tanowitz H. B., Wittner M. Specific allergic sensitization to Strongyloides antigens in human strongyloidiasis. Lab Invest. 1983 May;48(5):633–638. [PubMed] [Google Scholar]
  43. Genta R. M., Schad G. A., Hellman M. E. Strongyloides stercoralis: parasitological, immunological and pathological observations in immunosuppressed dogs. Trans R Soc Trop Med Hyg. 1986;80(1):34–41. doi: 10.1016/0035-9203(86)90190-2. [DOI] [PubMed] [Google Scholar]
  44. Genta R. M. Strongyloides stercoralis: immunobiological considerations on an unusual worm. Parasitol Today. 1986 Sep;2(9):241–246. doi: 10.1016/0169-4758(86)90003-7. [DOI] [PubMed] [Google Scholar]
  45. Genta R. M., Weil G. J. Antibodies to Strongyloides stercoralis larval surface antigens in chronic strongyloidiasis. Lab Invest. 1982 Jul;47(1):87–90. [PubMed] [Google Scholar]
  46. Haggerty J. J., Jr, Sandler R. Strongyloidiasis presenting as depression: a case report. J Clin Psychiatry. 1982 Aug;43(8):340–341. [PubMed] [Google Scholar]
  47. Handler A. M., Maroy P. Ecdysteroid receptors in Drosophila melanogaster adult females. Mol Cell Endocrinol. 1989 May;63(1-2):103–109. doi: 10.1016/0303-7207(89)90086-5. [DOI] [PubMed] [Google Scholar]
  48. Harper J. S., 3rd, Genta R. M., Gam A., London W. T., Neva F. A. Experimental disseminated strongyloidiasis in Erythrocebus patas. I. Pathology. Am J Trop Med Hyg. 1984 May;33(3):431–443. doi: 10.4269/ajtmh.1984.33.431. [DOI] [PubMed] [Google Scholar]
  49. Harris R. A., Jr, Musher D. M., Fainstein V., Young E. J., Clarridge J. Disseminated strongyloidiasis. Diagnosis made by sputum examination. JAMA. 1980 Jul 4;244(1):65–66. doi: 10.1001/jama.244.1.65. [DOI] [PubMed] [Google Scholar]
  50. Higenbottam T. W., Heard B. E. Opportunistic pulmonary strongyloidiasis complicating asthma treated with steroids. Thorax. 1976 Apr;31(2):226–233. doi: 10.1136/thx.31.2.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Igra-Siegman Y., Kapila R., Sen P., Kaminski Z. C., Louria D. B. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis. 1981 May-Jun;3(3):397–407. doi: 10.1093/clinids/3.3.397. [DOI] [PubMed] [Google Scholar]
  52. Kane M. G., Luby J. P., Krejs G. J. Intestinal secretion as a cause of hypokalemia and cardiac arrest in a patient with strongyloidiasis. Dig Dis Sci. 1984 Aug;29(8):768–772. doi: 10.1007/BF01312953. [DOI] [PubMed] [Google Scholar]
  53. Kennedy S., Campbell R. M., Lawrence J. E., Nichol G. M., Rao D. M. A case of severe Strongyloides stercoralis infection with jejunal perforation in an Australian ex-prisoner-of-war. Med J Aust. 1989 Jan 16;150(2):92–93. doi: 10.5694/j.1326-5377.1989.tb136371.x. [DOI] [PubMed] [Google Scholar]
  54. Klein R. A., Cleri D. J., Doshi V., Brasitus T. A. Disseminated Strongyloides stercoralis: a fatal case eluding diagnosis. South Med J. 1983 Nov;76(11):1438–1440. doi: 10.1097/00007611-198311000-00030. [DOI] [PubMed] [Google Scholar]
  55. Kuberski T. T., Gabor E. P., Boudreaux D. Disseminated strongyloidiasis. A complication of the immunosuppressed host. West J Med. 1975 Jun;122(6):504–508. [PMC free article] [PubMed] [Google Scholar]
  56. Lambroza A., Dannenberg A. J. Eosinophilic ascites due to hyperinfection with Strongyloides stercoralis. Am J Gastroenterol. 1991 Jan;86(1):89–91. [PubMed] [Google Scholar]
  57. Lansoud-Soukate J., Gharib B., Baswaid S., Capron A., de Reggi M. Ecdysteroid-like compounds in the serum and urine of African patients infected with Loa loa and Mansonella perstans microfilariae. Trans R Soc Trop Med Hyg. 1990 Mar-Apr;84(2):269–271. doi: 10.1016/0035-9203(90)90283-k. [DOI] [PubMed] [Google Scholar]
  58. Leelarasamee A., Nimmannit S., Na Nakorn S., Aswapokee N., Aswapokee P., Benjasuratwong Y. Disseminated strongyloidiasis: report of seven cases. Southeast Asian J Trop Med Public Health. 1978 Dec;9(4):539–542. [PubMed] [Google Scholar]
  59. Lucas S. B. Missing infections in AIDS. Trans R Soc Trop Med Hyg. 1990;84 (Suppl 1):34–38. doi: 10.1016/0035-9203(90)90453-l. [DOI] [PubMed] [Google Scholar]
  60. López J. E., Marcano-Torres M., Peña J. R., Quintini A., Malpica C. C., López J. E., López Salazar Y. Hepatitis granulomatosa producida por el Strongyloides stercoralis. Presentación de un caso con confirmación histopatológica. G E N. 1984 Jul-Dec;38(3-4):133–143. [PubMed] [Google Scholar]
  61. Maayan S., Wormser G. P., Widerhorn J., Sy E. R., Kim Y. H., Ernst J. A. Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome. Am J Med. 1987 Nov;83(5):945–948. doi: 10.1016/0002-9343(87)90656-5. [DOI] [PubMed] [Google Scholar]
  62. McLarnon M., Ma P. Brain stem glioma complicated by Strongyloides stercoralis. Ann Clin Lab Sci. 1981 Nov-Dec;11(6):546–549. [PubMed] [Google Scholar]
  63. McRury J., De Messias I. T., Walzer P. D., Huitger T., Genta R. M. Specific IgE responses in human strongyloidiasis. Clin Exp Immunol. 1986 Sep;65(3):631–638. [PMC free article] [PubMed] [Google Scholar]
  64. Mercer J. G., Munn A. E., Arme C., Rees H. H. Analysis of ecdysteroids in different developmental stages of Hymenolepis diminuta. Mol Biochem Parasitol. 1987 Aug;25(1):61–71. doi: 10.1016/0166-6851(87)90019-3. [DOI] [PubMed] [Google Scholar]
  65. Milder J. E., Walzer P. D., Kilgore G., Rutherford I., Klein M. Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. Gastroenterology. 1981 Jun;80(6):1481–1488. [PubMed] [Google Scholar]
  66. Milner P. F., Irvine R. A., Barton C. J., Bras G., Richards R. Intestinal malabsorption in Strongyloides stercoralis infestation. Gut. 1965 Dec;6(6):574–581. doi: 10.1136/gut.6.6.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Morgan J. S., Schaffner W., Stone W. J. Opportunistic strongyloidiasis in renal transplant recipients. Transplantation. 1986 Nov;42(5):518–524. doi: 10.1097/00007890-198611000-00016. [DOI] [PubMed] [Google Scholar]
  68. Moura H., Fernandes O., Viola J. P., Silva S. P., Passos R. H., Lima D. B. Enteric parasites and HIV infection: occurrence in AIDS patients in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 1989 Oct-Dec;84(4):527–533. doi: 10.1590/s0074-02761989000400010. [DOI] [PubMed] [Google Scholar]
  69. Murray J. F., Garay S. M., Hopewell P. C., Mills J., Snider G. L., Stover D. E. NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop. Am Rev Respir Dis. 1987 Feb;135(2):504–509. doi: 10.1164/arrd.1987.135.2.504. [DOI] [PubMed] [Google Scholar]
  70. Nakada K., Yamaguchi K., Furugen S., Nakasone T., Nakasone K., Oshiro Y., Kohakura M., Hinuma Y., Seiki M., Yoshida M. Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis. Int J Cancer. 1987 Aug 15;40(2):145–148. doi: 10.1002/ijc.2910400203. [DOI] [PubMed] [Google Scholar]
  71. Nera F. A., Murphy E. L., Gam A., Hanchard B., Figueroa J. P., Blattner W. A. Antibodies to Strongyloides stercoralis in healthy Jamaican carriers of HTLV-1. N Engl J Med. 1989 Jan 26;320(4):252–253. doi: 10.1056/NEJM198901263200416. [DOI] [PubMed] [Google Scholar]
  72. Newton R. C., Limpuangthip P., Greenberg S., Gam A., Neva F. A. Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression. Am J Med. 1992 Feb;92(2):202–208. doi: 10.1016/0002-9343(92)90113-p. [DOI] [PubMed] [Google Scholar]
  73. Noodleman J. S. Eosinophilic appendicitis. Demonstration of Strongyloides stercoralis as a causative agent. Arch Pathol Lab Med. 1981 Mar;105(3):148–149. [PubMed] [Google Scholar]
  74. Petithory J. C., Derouin F. AIDS and strongyloidiasis in Africa. Lancet. 1987 Apr 18;1(8538):921–921. doi: 10.1016/s0140-6736(87)92896-0. [DOI] [PubMed] [Google Scholar]
  75. Pillay S. V. Hyperinfection with Strongyloides stercoralis. A report of 3 cases. S Afr Med J. 1978 Oct 14;54(16):670–672. [PubMed] [Google Scholar]
  76. Poltera A. A., Katsimbura N. Granulomatous hepatitis due to Strongyloides stercoralis. J Pathol. 1974 Aug;113(4):241–246. doi: 10.1002/path.1711130408. [DOI] [PubMed] [Google Scholar]
  77. Purtilo D. T., Meyers W. M., Connor D. H. Fatal strongyloidiasis in immunosuppressed patients. Am J Med. 1974 Apr;56(4):488–493. doi: 10.1016/0002-9343(74)90481-1. [DOI] [PubMed] [Google Scholar]
  78. Quiñones Soto R. A., Harrington P. T., Gutiérrez Núez J. J., Ramírez Ronda C. H., Bermúdez R. H. Estrongiloidiasis en el paciente inmunocomprometido. Bol Asoc Med P R. 1981 Nov;73(11):562–566. [PubMed] [Google Scholar]
  79. René E., Marche C., Régnier B., Saimot A. G., Vittecoq B., Matheron S., Le Port C., Bricaire F., Bure A., Brun-Vezinet C. Manifestations digestives du syndrome d'immunodéficience acquise (SIDA): étude chez 26 patients. Gastroenterol Clin Biol. 1985 Apr;9(4):327–335. [PubMed] [Google Scholar]
  80. Rivera E., Maldonado N., Vélez-García E., Grillo A. J., Malaret G. Hyperinfection syndrome with Strongyloides stercoralis. Ann Intern Med. 1970 Feb;72(2):199–204. doi: 10.7326/0003-4819-72-2-199. [DOI] [PubMed] [Google Scholar]
  81. Schad G. A., Aikens L. M., Smith G. Strongyloides stercoralis: is there a canonical migratory route through the host? J Parasitol. 1989 Oct;75(5):740–749. [PubMed] [Google Scholar]
  82. Schad G. A. Cyclosporine may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients. J Infect Dis. 1986 Jan;153(1):178–178. doi: 10.1093/infdis/153.1.178. [DOI] [PubMed] [Google Scholar]
  83. Schad G. A., Hellman M. E., Muncey D. W. Strongyloides stercoralis: hyperinfection in immunosuppressed dogs. Exp Parasitol. 1984 Jun;57(3):287–296. doi: 10.1016/0014-4894(84)90103-6. [DOI] [PubMed] [Google Scholar]
  84. Scowden E. B., Schaffner W., Stone W. J. Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Medicine (Baltimore) 1978 Nov;57(6):527–544. [PubMed] [Google Scholar]
  85. Seth V., Beotra A. Malnutrition and immune system. Indian Pediatr. 1986 Apr;23(4):277–302. [PubMed] [Google Scholar]
  86. Setia U., Bhatia G. Pancreatic cystadenocarcinoma associated with strongyloides. Am J Med. 1984 Jul;77(1):173–175. doi: 10.1016/0002-9343(84)90456-x. [DOI] [PubMed] [Google Scholar]
  87. Shelhamer J. H., Neva F. A., Finn D. R. Persistent strongyloidiasis in an immunodeficient patient. Am J Trop Med Hyg. 1982 Jul;31(4):746–751. doi: 10.4269/ajtmh.1982.31.746. [DOI] [PubMed] [Google Scholar]
  88. Smith J. D., Goette D. K., Odom R. B. Larva currens. Cutaneous strongyloidiasis. Arch Dermatol. 1976 Aug;112(8):1161–1163. [PubMed] [Google Scholar]
  89. Vieyra-Herrera G., Becerril-Carmona G., Padua-Gabriel A., Jessurun J., Alonso-de Ruiz P. Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome. Acta Cytol. 1988 Mar-Apr;32(2):277–278. [PubMed] [Google Scholar]
  90. West B. C., Wilson J. P. Subconjunctival corticosteroid therapy complicated by hyperinfective strongyloidiasis. Am J Ophthalmol. 1980 Jun;89(6):854–857. doi: 10.1016/0002-9394(80)90179-8. [DOI] [PubMed] [Google Scholar]
  91. Williford M. E., Foster W. L., Jr, Halvorsen R. A., Thompson W. M. Emphysematous gastritis secondary to disseminated stronglyloidiasis. Gastrointest Radiol. 1982;7(2):123–126. doi: 10.1007/BF01887624. [DOI] [PubMed] [Google Scholar]
  92. Willis A. J., Nwokolo C. Steroid therapy and strongyloidiasis. Lancet. 1966 Jun 25;1(7452):1396–1398. doi: 10.1016/s0140-6736(66)90303-5. [DOI] [PubMed] [Google Scholar]
  93. Yamaguchi K., Matutes E., Catovsky D., Galton D. A., Nakada K., Takatsuki K. Strongyloides stercoralis as candidate co-factor for HTLV-I-induced leukaemogenesis. Lancet. 1987 Jul 11;2(8550):94–95. doi: 10.1016/s0140-6736(87)92752-8. [DOI] [PubMed] [Google Scholar]
  94. da Silva O. A., Amaral C. F., da Silveira J. C., López M., Pittella J. E. Hypokalemic respiratory muscle paralysis following Strongyloides stercoralis hyperinfection: a case report. Am J Trop Med Hyg. 1981 Jan;30(1):69–73. doi: 10.4269/ajtmh.1981.30.69. [DOI] [PubMed] [Google Scholar]
  95. de Messias I. T., Telles F. Q., Boaretti A. C., Sliva S., Guimarres L. M., Genta R. M. Clinical, immunological and epidemiological aspects of strongyloidiasis in an endemic area of Brazil. Allergol Immunopathol (Madr) 1987 Jan-Feb;15(1):37–41. [PubMed] [Google Scholar]
  96. de PAOLA, DIAS L. B., da SILVA J. Enteritis due to Strongyloides stercoralis. A report of 5 fatal cases. Am J Dig Dis. 1962 Dec;7:1086–1098. doi: 10.1007/BF02232985. [DOI] [PubMed] [Google Scholar]
  97. von Kuster L. C., Genta R. M. Cutaneous manifestations of strongyloidiasis. Arch Dermatol. 1988 Dec;124(12):1826–1830. doi: 10.1001/archderm.124.12.1826. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES